+00 999 123 456


  • In vitro/in vivo Met ID for small molecules and peptide therapeutics
  • Early-stage programs: Met ID for lead optimization (metabolic soft points, in vitro/in vivo correlation)
  • Later stage programs: definitive Met ID with cross species comparison
  • Metabolite exposure for safety assessment
  • Simultaneous qualitative and quantitative analysis (Qual/Quan approach)